116 related articles for article (PubMed ID: 36573569)
1. Performance of risk prediction models in breast cancer screening among women in Cyprus.
Danladi C; Serakinci N
East Mediterr Health J; 2022 Dec; 28(12):888-895. PubMed ID: 36573569
[TBL] [Abstract][Full Text] [Related]
2. 10-year performance of four models of breast cancer risk: a validation study.
Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
[TBL] [Abstract][Full Text] [Related]
3. Validating the IBIS and BOADICEA Models for Predicting Breast Cancer Risk in the Iranian Population.
Ghoncheh M; Ziaee F; Karami M; Poorolajal J
Clin Breast Cancer; 2017 Jun; 17(3):e113-e118. PubMed ID: 28216418
[TBL] [Abstract][Full Text] [Related]
4. Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.
Quante AS; Whittemore AS; Shriver T; Hopper JL; Strauch K; Terry MB
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25956172
[TBL] [Abstract][Full Text] [Related]
5. Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China.
Zhang L; Jie Z; Xu S; Zhang L; Guo X
Med Sci Monit; 2018 Aug; 24():5528-5532. PubMed ID: 30089770
[TBL] [Abstract][Full Text] [Related]
6. Assessing BRCA carrier probabilities in extended families.
Barcenas CH; Hosain GM; Arun B; Zong J; Zhou X; Chen J; Cortada JM; Mills GB; Tomlinson GE; Miller AR; Strong LC; Amos CI
J Clin Oncol; 2006 Jan; 24(3):354-60. PubMed ID: 16421416
[TBL] [Abstract][Full Text] [Related]
7. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium.
Fischer C; Kuchenbäcker K; Engel C; Zachariae S; Rhiem K; Meindl A; Rahner N; Dikow N; Plendl H; Debatin I; Grimm T; Gadzicki D; Flöttmann R; Horvath J; Schröck E; Stock F; Schäfer D; Schwaab I; Kartsonaki C; Mavaddat N; Schlegelberger B; Antoniou AC; Schmutzler R;
J Med Genet; 2013 Jun; 50(6):360-7. PubMed ID: 23564750
[TBL] [Abstract][Full Text] [Related]
9. Risk Prediction Model Development for Late On-Set Breast Cancer Screening in Low- and Middle-Income Societies: A Model Study for North Cyprus.
Danladi CD; Serakinci N
Healthcare (Basel); 2020 Jul; 8(3):. PubMed ID: 32708661
[No Abstract] [Full Text] [Related]
10. Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.
Ståhlbom AK; Johansson H; Liljegren A; von Wachenfeldt A; Arver B
Fam Cancer; 2012 Mar; 11(1):33-40. PubMed ID: 22124624
[TBL] [Abstract][Full Text] [Related]
11. Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk.
Allman R; Mu Y; Dite GS; Spaeth E; Hopper JL; Rosner BA
Breast Cancer Res Treat; 2023 Apr; 198(2):335-347. PubMed ID: 36749458
[TBL] [Abstract][Full Text] [Related]
12. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
[TBL] [Abstract][Full Text] [Related]
14. Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
McCarthy AM; Guan Z; Welch M; Griffin ME; Sippo DA; Deng Z; Coopey SB; Acar A; Semine A; Parmigiani G; Braun D; Hughes KS
J Natl Cancer Inst; 2020 May; 112(5):489-497. PubMed ID: 31556450
[TBL] [Abstract][Full Text] [Related]
15. Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort.
MacInnis RJ; Knight JA; Chung WK; Milne RL; Whittemore AS; Buchsbaum R; Liao Y; Zeinomar N; Dite GS; Southey MC; Goldgar D; Giles GG; Kurian AW; ; Andrulis IL; John EM; Daly MB; Buys SS; Phillips KA; Hopper JL; Terry MB
J Natl Cancer Inst; 2021 Jun; 113(6):785-791. PubMed ID: 33301022
[TBL] [Abstract][Full Text] [Related]
16. An investigation of breast cancer risk factors in Cyprus: a case control study.
Hadjisavvas A; Loizidou MA; Middleton N; Michael T; Papachristoforou R; Kakouri E; Daniel M; Papadopoulos P; Malas S; Marcou Y; Kyriacou K
BMC Cancer; 2010 Aug; 10():447. PubMed ID: 20727220
[TBL] [Abstract][Full Text] [Related]
17. Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre.
MacInnis RJ; Bickerstaffe A; Apicella C; Dite GS; Dowty JG; Aujard K; Phillips KA; Weideman P; Lee A; Terry MB; Giles GG; Southey MC; Antoniou AC; Hopper JL
Br J Cancer; 2013 Sep; 109(5):1296-301. PubMed ID: 23942072
[TBL] [Abstract][Full Text] [Related]
18. Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study).
Gao F; Machin D; Chow KY; Sim YF; Duffy SW; Matchar DB; Goh CH; Chia KS
BMC Cancer; 2012 Nov; 12():529. PubMed ID: 23164155
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
